UQ Centre for Clinical Research
Sunil R. Lakhani has not added Biography.
If you are Sunil R. Lakhani and would like to personalize this page please email our Author Liaison for assistance.
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2005 | Pubmed ID: 16033833
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
European journal of cancer (Oxford, England : 1990) Sep, 2006 | Pubmed ID: 16876991
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
Breast cancer research : BCR , 2007 | Pubmed ID: 17217540
Current and future approach to the pathologist's assessment for targeted therapy in breast cancer.
Pathology Jan, 2009 | Pubmed ID: 19089744
Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.
Future oncology (London, England) Mar, 2009 | Pubmed ID: 19284381
Pathology of hereditary breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc May, 2010 | Pubmed ID: 20436502
The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.
Familial cancer Dec, 2010 | Pubmed ID: 20577821
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.
Breast cancer research : BCR , 2010 | Pubmed ID: 20604919
Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges.
Human pathology Feb, 2011 | Pubmed ID: 21106225
Molecular classification of breast cancer: is it time to pack up our microscopes?
Pathology Jan, 2011 | Pubmed ID: 21240058
Phenotype-genotype correlation in familial breast cancer.
Journal of mammary gland biology and neoplasia Apr, 2011 | Pubmed ID: 21400086
Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization.
Endocrine pathology Jun, 2011 | Pubmed ID: 21499728
Molecular aspects of breast cancer metastasis to the brain.
Genetics research international , 2011 | Pubmed ID: 22567347
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Breast cancer research and treatment Aug, 2012 | Pubmed ID: 22718308
Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer.
Molecular cancer therapeutics Oct, 2012 | Pubmed ID: 22807578
Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.
PloS one , 2012 | Pubmed ID: 22815804
Expression profiling of archival tumors for long-term health studies.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2012 | Pubmed ID: 23136189
MicroRNA-182-5p targets a network of genes involved in DNA repair.
RNA (New York, N.Y.) Feb, 2013 | Pubmed ID: 23249749
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Nature genetics Apr, 2013 | Pubmed ID: 23535731
In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity.
PloS one , 2013 | Pubmed ID: 23750209
Signatures of mutational processes in human cancer.
Nature Aug, 2013 | Pubmed ID: 23945592
Metastatic progression of breast cancer: insights from 50 years of autopsies.
The Journal of pathology Jan, 2014 | Pubmed ID: 24122263
Is the one-step nucleic acid amplification assay better for intra-operative assessment of breast sentinel nodes?
ANZ journal of surgery Oct, 2014 | Pubmed ID: 24397867
Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation.
PloS one , 2014 | Pubmed ID: 24489791
Molecular classification of breast cancer.
Virchows Archiv : an international journal of pathology Jul, 2014 | Pubmed ID: 24878755
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
Oncotarget Feb, 2015 | Pubmed ID: 25668816
ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype.
Nature communications Mar, 2015 | Pubmed ID: 25813983
Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.
Breast cancer research : BCR Jan, 2015 | Pubmed ID: 25849106
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.
PloS one , 2015 | Pubmed ID: 25969993
An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.
The Journal of pathology Mar, 2016 | Pubmed ID: 26510554
Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer.
International journal of cancer Apr, 2016 | Pubmed ID: 26619948
TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications.
BMC cancer Dec, 2015 | Pubmed ID: 26703884
High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations.
Breast cancer research : BCR Feb, 2016 | Pubmed ID: 26861772
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.
American journal of human genetics 05, 2016 | Pubmed ID: 27087319
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nature 06, 2016 | Pubmed ID: 27135926
The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.
Scientific reports 05, 2016 | Pubmed ID: 27148852
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 10, 2016 | Pubmed ID: 27363491
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Human molecular genetics 08, 2016 | Pubmed ID: 27378691
SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer.
Oncotarget 11, 2016 | Pubmed ID: 27637080
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.
Nature communications Sep, 2016 | Pubmed ID: 27666519
'Omics Approaches in Breast Cancer Research and Clinical Practice.
Advances in anatomic pathology Nov, 2016 | Pubmed ID: 27740960
Current topics in breast pathology: expert perspectives.
Pathology Feb, 2017 | Pubmed ID: 28069256
Environmental factors in breast cancer invasion: a mathematical modelling review.
Pathology Feb, 2017 | Pubmed ID: 28081961
Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context.
International journal of molecular sciences Jan, 2017 | Pubmed ID: 28098771
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers.
Nature genetics Mar, 2017 | Pubmed ID: 28112740
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
Nature medicine Apr, 2017 | Pubmed ID: 28288110
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 07, 2017 | Pubmed ID: 28338653
Relationship of the Breast Ductal Carcinoma Immune Microenvironment with Clinicopathological and Genetic Features.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2017 | Pubmed ID: 28611201
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
Breast cancer research and treatment 01, 2018 | Pubmed ID: 28889351
Association analysis identifies 65 new breast cancer risk loci.
Nature Nov, 2017 | Pubmed ID: 29059683
Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
The Journal of pathology 04, 2018 | Pubmed ID: 29344954
Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers.
Histopathology Jul, 2018 | Pubmed ID: 29465777
Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient.
Breast cancer research and treatment Jul, 2018 | Pubmed ID: 29468485
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer.
EMBO molecular medicine 09, 2018 | Pubmed ID: 30108112
Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.
The journal of pathology. Clinical research 01, 2019 | Pubmed ID: 30246500
Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.
The Journal of pathology 02, 2019 | Pubmed ID: 30350370
Recent advances in breast cancer research impacting clinical diagnostic practice.
The Journal of pathology 04, 2019 | Pubmed ID: 30426489
Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nature 02, 2019 | Pubmed ID: 30659290
The circular RNome of primary breast cancer.
Genome research 03, 2019 | Pubmed ID: 30692147
Diff-Quik Cytology Smears from Endobronchial Ultrasound Transbronchial Needle Aspiration Lymph Node Specimens as a Source of DNA for Next-Generation Sequencing Instead of Cell Blocks.
Respiration; international review of thoracic diseases , 2019 | Pubmed ID: 30731462
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.
JCI insight 02, 2019 | Pubmed ID: 30830863
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases.
International journal of molecular sciences Mar, 2019 | Pubmed ID: 30875730
Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment.
International journal of molecular sciences May, 2019 | Pubmed ID: 31121957
A Molecular and Morphological Deep-Dive Into Metaplastic Breast Cancers.
Cancer informatics , 2019 | Pubmed ID: 31205411
LobSig is a multigene predictor of outcome in invasive lobular carcinoma.
NPJ breast cancer , 2019 | Pubmed ID: 31263747
Breast Cancer Heterogeneity in Primary and Metastatic Disease.
Advances in experimental medicine and biology , 2019 | Pubmed ID: 31456181
Non-coding RNAs underlie genetic predisposition to breast cancer.
Genome biology 01, 2020 | Pubmed ID: 31910864
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
The Journal of pathology 04, 2020 | Pubmed ID: 32129476
Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer.
Cancers Mar, 2020 | Pubmed ID: 32244556
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer.
Life science alliance 07, 2020 | Pubmed ID: 32423906
Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor-Positive Breast Cancer.
JAMA network open 07, 2020 | Pubmed ID: 32633764
Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1.
Frontiers in cell and developmental biology , 2020 | Pubmed ID: 32766238
Using whole-genome sequencing data to derive the homologous recombination deficiency scores.
NPJ breast cancer , 2020 | Pubmed ID: 32818150
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1.
British journal of cancer 11, 2020 | Pubmed ID: 32939056
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S) in human breast cancers and matching brain metastases.
Therapeutic advances in medical oncology , 2020 | Pubmed ID: 33014146
The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence.
British journal of cancer 01, 2021 | Pubmed ID: 33024263
Lobular carcinoma in situ: diagnostic criteria and molecular correlates.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 01, 2021 | Pubmed ID: 33024303
Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related.
Clinical case reports Dec, 2020 | Pubmed ID: 33363813
Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.
Breast cancer research : BCR 01, 2021 | Pubmed ID: 33413533
An Update on the Molecular Pathology of Metaplastic Breast Cancer.
Breast cancer (Dove Medical Press) , 2021 | Pubmed ID: 33664587
Spatial profiling technologies and applications for brain cancers.
Expert review of molecular diagnostics Mar, 2021 | Pubmed ID: 33685321
Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development.
Cancers 04, 2021 | Pubmed ID: 33917078
The Genomic Landscape of Lobular Breast Cancer.
Cancers Apr, 2021 | Pubmed ID: 33919581
Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases.
Biology 05, 2021 | Pubmed ID: 34064871
Altered Calcium Influx Pathways in Cancer-Associated Fibroblasts.
Biomedicines Jun, 2021 | Pubmed ID: 34208665
Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. 2021, , 1950.
Cancers Aug, 2021 | Pubmed ID: 34439402
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.
Cancers Sep, 2021 | Pubmed ID: 34572879
Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients.
Cancers Jan, 2022 | Pubmed ID: 35008424
Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
BMC cancer Jan, 2022 | Pubmed ID: 35057759
Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases.
Cancers Jan, 2022 | Pubmed ID: 35158800
Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility.
Diseases (Basel, Switzerland) Feb, 2022 | Pubmed ID: 35225863
N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease.
BMC cancer Mar, 2022 | Pubmed ID: 35346112
Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.
NPJ breast cancer May, 2022 | Pubmed ID: 35501337
The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in point.
Pathology Jun, 2022 | Pubmed ID: 35778289
Malcolm Lim1,
Nicholas Fletcher2,
Amy McCart Reed1,
Melanie Flint3,
Kristofer Thurecht2,
Jodi Saunus*,1,4,
Sunil R. Lakhani*,1,5
1UQ Centre for Clinical Research, The University of Queensland,
2Centre for Advanced Imaging, Australian Institute for Bioengineering and Nanotechnology and ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland,
3School of Biomedical Sciences, The University of Queensland,
4Mater Research and Mater Research Institute, The University of Queensland,
5Pathology Queensland, Royal Brisbane Women's Hospital